READ MORE yas/yasmin LEGAL NEWS
According to Bloomberg News, on April 10, the US Food and Drug Administration (FDA) ordered Bayer and other makers of birth control pills to strengthen blood-clot warnings on their products. Consequently, oral contraceptives that contain a synthetic hormone called drospirenone will have warnings on the labels stating that research shows there may be triple the risk for clots with pills such as Yasmin/Yaz. These warnings are also based on an FDA examination of data on more than 835,000 women who took oral contraceptives containing drospirenone, including Yasmin/Yas.